Switching from alternatives to Revenia is worth a discussion.
1. I don’t think the health of the drive to look good although aging needs explaining, nor the fact the market will only grow as people living in developing countries accumulate more wealth. People will seek better aesthetics treatment and will generate demand to get the newest, best therapy. That’s one very powerful driver for adoption.
2. Perhaps more important is the nature and dynamics of the Aesthetics providers (I’m talking about using Renevia solo). These are, on the most part, private small businesses such as Spas, quasi medical (Plastic Surgery Clinique’s). These players operate almost without moat as businesses and depend on their survival on retaining the costumers. You really need to go and see how these outfits operates: from Botox parties (doctors comes and injects 10-15 middle aged women at a private residence) or small spa, with women entering a room for 5-7 minutes, being injected and getting out. These outfits are usually competing against one another on price and / or technology. Customer loyalty is very low and these types of procedures are high gross margin (and more importantly don’t require high capex on machines such as laser hair removal, etc). The result is a natural business push by proprietors to get in people on the lower margin commodity business (such as hair removal or brow treatment or what have you) and then, upsell this type of high margin service, which only needs a nurse or doctor that can handle many people in one hour and generate large amount of profit. The bottom line is there is always a “nuclear arms race” to provide the best treatment, the newest option. Those that don’t – go bankrupt. So between the economic incentive and the end client demand, believe me, I feel confident in saying the demand for the treatment is going to take care of the uptake. Only little marketing is needed to inform the market about the new product. This is not Hospitals or Medical Doctors or some other very slow process (such as insurance companies requiring proof). The Fads that are in the market are ridiculous and still sell. This is good science good product better results. This is the first (I believe) market to blast forward.
3. Other more “Clinical” uses will pick up second as sheer private useage will increase penetration into society and act as a sort of Goodwill generator.
4. A hint confirming my assessment is how the Company is thinking about the possibility to use Renevia as a breast implant in the recent podcast . This is the private business setting Im talking about and I think they are dead on a big hungry market.
5. Much later will come all sort of more medical usage of the product and these will be longer term therapies slower to uptake as the medical and insurance institution are briefed and acquainted with the product and more research is done. The usage here will most likely be linked to the original purpose of the product: a delivery platform for the Stem Cell treatment the company is developing.
Hope this helps, TJ.
